Northern Trust
OREX

Northern Trust’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Northern Trust’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-26,943
Closed -$34K – 4348
2017
Q4 		$34K Buy
26,943
+570
+2% +$928 ﹤0.01% 4112
2017
Q3 		$56K Buy
26,373
+106
+0.4% +$259 ﹤0.01% 4049
2017
Q2 		$76K Sell
26,267
-122
-0.5% -$366 ﹤0.01% 4029
2017
Q1 		$90K Sell
26,389
-148
-0.6% -$584 ﹤0.01% 3978
2016
Q4 		$46K Buy
26,537
+6,410
+32% +$15.1K ﹤0.01% 4019
2016
Q3 		$66K Sell
20,127
-1,196
-6% -$4.52K ﹤0.01% 3968
2016
Q2 		$91K Sell
21,323
-102,421
-83% -$463K ﹤0.01% 3916
2016
Q1 		$696K Sell
123,744
-308
-0.2% -$4K ﹤0.01% 3366
2015
Q4 		$2.13M Buy
124,052
+2,789
+2% +$66.5K ﹤0.01% 3030
2015
Q3 		$2.56M Sell
121,263
-14,299
-11% -$490K ﹤0.01% 2892
2015
Q2 		$6.71M Sell
135,562
-2,261
-2% -$135K ﹤0.01% 2326
2015
Q1 		$10.8M Buy
137,823
+700
+0.5% +$43.4K ﹤0.01% 2030
2014
Q4 		$8.31M Sell
137,123
-2,906
-2% -$146K ﹤0.01% 2157
2014
Q3 		$5.96M Buy
140,029
+1,921
+1% +$103K ﹤0.01% 2401
2014
Q2 		$8.54M Sell
138,108
-693
-0.5% -$40.3K ﹤0.01% 2145
2014
Q1 		$9.02M Sell
138,801
-12,239
-8% -$828K ﹤0.01% 2184
2013
Q4 		$8.5M Buy
151,040
+14,138
+10% +$794K ﹤0.01% 2192
2013
Q3 		$8.39M Buy
136,902
+7,347
+6% +$498K ﹤0.01% 2146
2013
Q2 		$7.57M Buy
+129,555
New +$7.97M ﹤0.01% 2129

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust's OREX Position: Q1 2018 in Review

Northern Trust sold out of Orexigen Therapeutics, Inc. (OREX) in Q1 2018, closing a stake of 26,943 shares — an estimated $34K sold.

Northern Trust first reported a position in OREX in Q2 2013 and held it in 19 quarters. The position peaked at $10.8M in Q1 2015. 27 funds tracked by Wall St. Rank hold OREX as of Q1 2018.

  • Northern Trust reported no remaining Orexigen Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Northern Trust sold 26,943 Orexigen Therapeutics, Inc. shares in Q1 2018, an estimated $34K.
  • Northern Trust first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 19 quarters.
  • Northern Trust's Orexigen Therapeutics, Inc. position peaked at $10.8M in Q1 2015.
  • 27 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q1 2018.

Based on Northern Trust's 13F filing for Q1 2018, filed 9 May 2018.